Biohybrid devices and encapsulation technologies for engineering a bioartificial pancreas

Cell Transplantation

Volumn 17, Issue 9, 2008, Pages 997-1003

  Fort, Alexander ^a   Fort, Nicholas ^a   Ricordi, Camillo ^a,b,c,d,e   Stabler, Cherie L ^a,b,c,f  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c University of Miami   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f NONE   (United States)

Author keywords

Bioartificial pancreas; Biohybrid device; Diabetes; Encapsulation

Indexed keywords

AGAROSE; ALGINIC ACID; BARIUM; BASIC FIBROBLAST GROWTH FACTOR; BELATACEPT; BIOMATERIAL; CD28 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; CYCLOSPORIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ETHYLENE VINYL ALCOHOL COPOLYMER; GADOLINIUM CHLORIDE; MACROGOL; RAPAMYCIN; TACROLIMUS;

ANTIGEN RECOGNITION; ARTIFICIAL PANCREAS; BIOCOMPATIBILITY; DEVICE; GLYCEMIC CONTROL; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; MACACA; MECHANICAL STRESS; MICROENCAPSULATION; NANOENCAPSULATION; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PORTAL VEIN; PRIORITY JOURNAL; REVIEW; SWINE; VASCULARIZATION;

ANIMALS; BIOARTIFICIAL ORGANS; DIABETES MELLITUS, TYPE 1; DRUG COMPOUNDING; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; TRANSPLANTATION TOLERANCE;

EID: 62549084765     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368908786991498     Document Type: Review

References (39)

1. al-Abdullah, I. H.; Anil Kumar, M. S.; Kelly-Sullivan, D.; Abouna, G. M. Site for unpurified islet transplantation is an important parameter for determination of the outcome of graft survival and function. Cell Transplant. 4(3):297-305; 1995.
2. Brown, D. L.; Meagher, P. J.; Knight, K. R.; Keramidaris, E.; Romeo-Meeuw, R.; Penington, A. J.; Morrison, W. A. Survival and function of transplanted islet cells on an in vivo, vascularized tissue engineering platform in the rat: A pilot study. Cell Transplant. 15(4):319-324; 2006.
3. Cardona, K.; Korbutt, G. S.; Milas, Z.; Lyon, J.; Cano, J.; Jiang, W.; Bello-Laborn, H.; Hacquoil, B.; Strobert, E.; Gangappa, S.; Weber, C. J.; Pearson, T. C.; Rajotte, R. V.; Larsen, C. P. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimula-tion pathways. Nat. Med. 12(3):304-306; 2006.
4. Cardona, K.; Milas, Z.; Strobert, E.; Cano, J.; Jiang, W.; Safley, S. A.; Gangappa, S.; Hering, B. J.; Weber, C. J.; Pearson, T. C.; Larsen, C. P. Engraftment of adult porcine islet xenografts in diabetic nonhuman primates through targeting of costimulation pathways. Am. J. Transplant. 7(10):2260-2268; 2007.
5. Chaffanjon, P. C.; Kenyon, N. M.; Ricordi, C.; Kenyon, N. S. Omental anatomy of non-human primates. Surg. Radiol. Anat. 27(4):287-291; 2005.
6. de Haan, B. J.; Faas, M. M.; de Vos, P. Factors influencing insulin secretion from encapsulated islets. Cell Transplant. 12(6):617-625; 2003.
7. de Vos, P.; de Haan, B. J.; de Haan, A.; van Zanten, J.; Faas, M. M. Factors influencing functional survival of microencapsulated islet grafts. Cell Transplant. 13(5):515-524; 2004.
8. Dusseault, J.; Tarn, S. K.; Menard, M.; Polizu, S.; Jour-dan, G.; Yahia, L.; Halle, J. P. Evaluation of alginate purification methods: Effect on polyphenol, endotoxin, and protein contamination. J. Biomed. Mater. Res. A 76(2): 243-251; 2006.
9. Figliuzzi, M.; Plati, T.; Cornolti, R.; Adobati, F.; Fagiani, A.; Rossi, L.; Remuzzi, G.; Remuzzi, A. Biocompatibility and function of microencapsulated pancreatic islets. Acta Biomater. 2(2):221-227; 2006.
10. Halberstadt, C. R.; Williams, D.; Emerich, D.; Goddard, M.; Vasconcellos, A. V.; Curry, W.; Bhatia, A.; Gores, P. F. Subcutaneous transplantation of islets into strepto-zocin-induced diabetic rats. Cell Transplant. 14(8):595-605; 2005.
11. Heywood, H. K.; Bader, D. L.; Lee, D. A. Rate of oxygen consumption by isolated articular chondrocytes is sensitive to medium glucose concentration. J. Cell. Physiol. 206(2):402-410; 2006.
12. Jang, J. Y.; Lee, D. Y.; Park, S. J.; Byun, Y. Immune reactions of lymphocytes and macrophages against PEG-grafted pancreatic islets. Biomaterials 25(17):3663-3669; 2004.
13. Jones, G. L.; Juszczak, M. T.; Hughes, S. J.; Kooner, P.; Powis, S. H.; Press, M. Time course and quantification of pancreatic islet revascularization following intraportal transplantation. Cell Transplant. 16(5):505-516; 2007.
14. Kendall, Jr., W. F.; Darrabie, M. D.; El-Shewy, H. M.; Opara, E. C. Effect of alginate composition and purity on alginate microspheres. J. Microencapsul. 21(8):821-828; 2004.
15. Kin, T.; Korbutt, G. S.; Rajotte, R. V. Survival and metabolic function of syngeneic rat islet grafts transplanted in the omental pouch. Am. J. Transplant. 3(3):281-285; 2003.
16. Kobayashi, T.; Aomatsu, Y.; Iwata, H.; Kin, T.; Kanehiro, H.; Hisanga, M.; Ko, S.; Nagao, M.; Harb, G.; Nakajima, Y. Survival of microencapsulated islets at 400 days posttransplantation in the omental pouch of NOD mice. Cell Transplant. 15(4):359-365; 2006.
17. Kobayashi, T.; Aomatsu, Y.; Kenehiro, H.; Hisanaga, M.; Nakajima, Y. Protection of NOD islet isograft from autoimmune destruction by agarose microencapsulation. Transplant. Proc. 35:484-485; 2003.
18. Lee, D. Y.; Lee, S.; Nam, J. H.; Byun, Y. Minimization of immunosuppressive therapy after islet transplantation: combined action of heme oxygenase-1 and PEGylation to islet. Am. J. Transplant. 6(8):1820-1828; 2006.
19. Lee, D. Y.; Nam, J. H.; Byun, Y. Effect of polyethylene glycol grafted onto islet capsules on prevention of spleno-cyte and cytokine attacks. J. Biomater. Sci. Polym. Ed. 15(6):753-766; 2004.
20. Lee, D. Y.; Park, S. J.; Nam, J. H.; Byun, Y. A combination therapy of PEGylation and immunosuppressive agent for successful islet transplantation. J. Control. Release 110(2):290-295;2006.
21. Lembert, N.; Wesche, J.; Petersen, P.; Doser, M.; Zschocke, P.; Becker, H. D.; Ammon, H. P. Encapsulation of islets in rough surface, hydroxymethylated polysulfone capillaries stimulates VEGF release and promotes vascularization after transplantation. Cell Transplant. 14(2-3): 97-108; 2005.
22. Lu, H. F.; Targonsky, E. D.; Wheeler, M. B.; Cheng, Y. L. Thermally induced gelable polymer networks for living cell encapsulation. Biotechnol. Bioeng. 96(1): 146-155; 2007.
23. Miki, A.; Rivas-Carrillo, J. D.; Navarro-Alvarez, N.; Soto-Gutierrez, A.; Chen, Y.; Tanaka, K.; Narushima, M.; Tabata, Y.; Okitsu, T.; Noguchi, H.; Matsumoto, S.; Tanaka, N.; Kobayashi, N. Maintenance of neovascularization at the implantation site of an artificial device by bFGF and endothelial cell transplant. Cell Transplant. 15(10):893-901;2006.
24. Miura, S.; Teramura, Y.; Iwata, H. Encapsulation of islets with ultra-thin polyion complex membrane through poly (ethylene glycol)-phospholipids anchored to cell membrane. Biomaterials 27(34):5828-5835; 2006.
25. Neuzillet, Y.; Giraud, S.; Lagorce, L.; Eugene, M.; Debre, P.; Richard, F.; Barrou, B. Effects of the molecular weight of peg molecules (8, 20 and 35 KDA) on cell function and allograft survival prolongation in pancreatic islets transplantation. Transplant. Proc. 38(7):2354-2355; 2006.
26. Noth, U.; Grohn, P.; Jork, A.; Zimmermann, U.; Haase, A.; Lutz, J. 19F-MRI in vivo determination of the partial oxygen pressure in perfluorocarbon-loaded alginate capsules implanted into the peritoneal cavity and different tissues. Magn. Reson. Med. 42(6): 1039-1047; 1999.
27. Nyberg, S. L.; Amiot, B.; Hardin, J.; Baskin-Bey, E.; Platt, J. L. Cytotoxic immune response to a xenogeneic bioartificial liver. Cell Transplant. 13(7-8):783-791; 2004.
28. Petruzzo, P.; Pibiri, L.; De Giudici, M. A.; Basta, G.; Calafiore, R.; Falorni, A.; Brunetti, P.; Brotzu, G. Xenotransplantation of microencapsulated pancreatic islets contained in a vascular prosthesis: Preliminary results. Transpl. Int. 4(4):200-204; 1991.
29. Pileggi, A.; Molano, R. D.; Ricordi, C.; Zahr, E.; Collins, J.; Valdes, R.; Inverardi, L. Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascu-larized device. Transplantaüon 81(9):1318-1324; 2006.
30. Prokop, A.; Kozlov, E.; Nun Non, S.; Dikov, M. M.; Sephel, G. C.; Whitsitt, J. S.; Davidson, J. M. Towards retrievable vascularized bioartificial pancreas: induction and long-lasting stability of polymeric mesh implant vascularized with the help of acidic and basic fibroblast growth factors and hydrogel coating. Diabetes Technol. Ther. 3(2):245-261; 2001."
31. Safley, S. A.; Kapp, L. M.; Tucker-Burden, C.; Hering, B.; Kapp, J. A.; Weber, C. J. Inhibition of cellular immune responses to encapsulated porcine islet xenografts by simultaneous blockade of two different costimulatory pathways. Transplantation 79(4):409-418; 2005.
32. Sun, A.; Parisius, W.; Macmorine, H.; Sefton, M.; Stone, R. An artificial pancreas containing cultured islets of Langerhans. Artif. Organs 4:275-278; 1980.
33. Teramura, Y.; Kaneda, Y.; Iwata, H. Islet-encapsulation in ultra-thin layer-by-layer membranes of poly(vinyl alcohol) anchored to poly(ethylene glycol)-lipids in the cell membrane. Biomaterials 28(32):4818-4825; 2007.
34. Toso, C.; Mathe, Z.; Morel, P.; Oberholzer, J.; Bosco, D.; Sainz-Vidal, D.; Hunkeler, D.; Buhler, L. H.; Wandrey, C.; Berney, T. Effect of microcapsule composition and short-term immunosuppression on intraportal biocompati-bility. Cell Transplant. 14(2-3):159-167; 2005.
35. Trivedi, N.; Steil, G. M.; Colton, C. K.; Bonner-Weir, S.; Weir, G. C. Improved vascularization of planar membrane diffusion devices following continuous infusion of vascular endothelial growth factor. Cell Transplant. 9(1): 115-124; 2000.
36. Wang, W.; Upshaw, L.; Strong, D. M.; Robertson, R. P.; Reems, J. Increased oxygen consumption rates in response to high glucose detected by a novel oxygen biosensor system in non-human primate and human islets. J. Endocrinol. 185(3):445-455; 2005.
37. Xie, D.; Smyth, C. A.; Eckstein, C.; Bilbao, G.; Mays, J.; Eckhoff, D. E.; Contreras, J. L. Cytoprotection of PEG-modified adult porcine pancreatic islets for improved xenotransplantation. Biomaterials 26(4):403-412; 2005.
38. Yun Lee, D.; Hee Nam, J.; Byun, Y. Functional and histological evaluation of transplanted pancreatic islets immu-noprotected by PEGylation and cyclosporine for 1 year. Biomaterials 28(11):1957-1966; 2007.
39. Zhang, W. J.; Laue, C.; Hyder, A.; Schrezenmeir, J. Purity of alginate affects the viability and fibrotic overgrowth of encapsulated porcine islet xenografts. Transplant. Proc. 33(7-8):3517-3519; 2001.